Lederle's Damox
Executive Summary
FDA's "Approved Rx Drug Products List with Therapeutic Equivalence Evaluations" supplement for Aug. 1984-Nov. 1984 incorrectly lists the patent expiration date for Diamox ("The Pink Sheet" Dec. 24, p. 10). The patent cited, #3584005 (not #3544005 as listed), is a process patent and therefore not valid for inclusion in FDA's listing. The list includes only chemical entity or use patents. Diamox will be deleted from future supplements
|
FDA's "Approved Rx Drug Products List with Therapeutic Equivalence
Evaluations" supplement for Aug. 1984-Nov. 1984 incorrectly lists
the patent expiration date for Diamox ("The Pink Sheet" Dec. 24, p.
10). The patent cited, #3584005 (not #3544005 as listed), is a
process patent and therefore not valid for inclusion in FDA's
listing. The list includes only chemical entity or use patents.
Diamox will be deleted from future supplements |